ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CMA accuses four pharmas of anticompetitive behaviour pharmatimes
May 28, 2019Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine, costing the NHS millions of pounds and breaking competition law.
Pharma Sources Insight January 2025
